Publication:
THE EFFECT OF 1,25-DIHYDROXYVITAMIN-D3 ON LYMPHOCYTE-TRANSFORMATION IN PATIENTS WITH CHRONIC-RENAL-FAILURE

dc.contributor.authorsALPDOGAN, O; OZGUN, S; LAWRENCE, R; OZENER, C; AKOGLU, E; AKOGLU, T
dc.date.accessioned2022-03-14T10:01:02Z
dc.date.accessioned2026-01-11T15:57:52Z
dc.date.available2022-03-14T10:01:02Z
dc.date.issued1995
dc.description.abstractThe changes in mitogen-induced lymphocyte response occurring in nine patients undergoing chronic hemodialysis and treated with 1,25 dihydroxyvitamin D-3 (0.5 mu g/day) were investigated, Prior to treatment the stimulation indices (SI) in patients with 15.4+/-4.2 for phytohemagglutinin (PHA) and 7.2+/-0.7 for conconavalin A (Con A), In the controls, stimulation indices were 44.4+/-13.5 and 20.2+/-5.3 for PHA and Con A, respectively, Following treatment, the stimulation indices increased to 36.9+/-6.2 for PHA (p<0.05) and 18.6+/-3.9 for Con A (p>0.05) indicating the beneficial effect of oral 1,25 dihydroxyvitamin Dg treatment on lymphocyte function in patients with chronic renal failure.
dc.identifier.doi10.2169/internalmedicine.34.240
dc.identifier.issn0918-2918
dc.identifier.pubmed7606089
dc.identifier.urihttps://hdl.handle.net/11424/243899
dc.identifier.wosWOS:A1995QU61000003
dc.language.isoeng
dc.publisherJAPAN SOC INTERNAL MEDICINE
dc.relation.ispartofINTERNAL MEDICINE
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectVITAMIN D
dc.subjectLYMPHOCYTE FUNCTION
dc.subjectCONCONAVALIN A
dc.subjectPHYTOHEMAGGLUTININ
dc.titleTHE EFFECT OF 1,25-DIHYDROXYVITAMIN-D3 ON LYMPHOCYTE-TRANSFORMATION IN PATIENTS WITH CHRONIC-RENAL-FAILURE
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage242
oaire.citation.issue4
oaire.citation.startPage240
oaire.citation.titleINTERNAL MEDICINE
oaire.citation.volume34

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
file.pdf
Size:
526.49 KB
Format:
Adobe Portable Document Format